Literature DB >> 22905350

The dilemma of prostate-specific antigen testing.

Robin Leach, Ian M Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22905350      PMCID： PMC5020903          DOI： 10.1001/archinternmed.2012.1226

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

2.  Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.

Authors:  Stephen B Williams; Simpa Salami; Meredith M Regan; Donna P Ankerst; John T Wei; Mark A Rubin; Ian M Thompson; Martin G Sanda
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

3.  Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors.

Authors:  Osama M Zaytoun; Thomas Anil; Ayman S Moussa; Li Jianbo; Khaled Fareed; J Stephen Jones
Journal:  Urology       Date:  2011-02-12       Impact factor: 2.649

4.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

5.  6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial.

Authors:  Anthony V D'Amico; Judith Manola; Marian Loffredo; Andrew A Renshaw; Alyssa DellaCroce; Philip W Kantoff
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

6.  Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.

Authors:  Lisa F Newcomb; James D Brooks; Peter R Carroll; Ziding Feng; Martin E Gleave; Peter S Nelson; Ian M Thompson; Daniel W Lin
Journal:  Urology       Date:  2009-09-16       Impact factor: 2.649

7.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Authors:  Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith Canby-Hagino; E David Crawford
Journal:  J Urol       Date:  2009-01-23       Impact factor: 7.450
  7 in total
  2 in total

1.  Cancer incidence among capacitor manufacturing workers exposed to polychlorinated biphenyls.

Authors:  Avima M Ruder; Misty J Hein; Nancy B Hopf; Martha A Waters
Journal:  Am J Ind Med       Date:  2017-01-06       Impact factor: 2.214

2.  Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.

Authors:  Julius O Nyalwidhe; Lucy R Betesh; Thomas W Powers; E Ellen Jones; Krista Y White; Tanya C Burch; Jasmin Brooks; Megan T Watson; Raymond S Lance; Dean A Troyer; O John Semmes; Anand Mehta; Richard R Drake
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.